Usefulness of a new tumor marker, Span-1, for the diagnosis of pancreatic cancer.

@article{Kiriyama1990UsefulnessOA,
  title={Usefulness of a new tumor marker, Span-1, for the diagnosis of pancreatic cancer.},
  author={Seiki Kiriyama and Tetsuo Hayakawa and Takaharu Kondo and Tokimune Shibata and Masamichi Kitagawa and Hideki Ono and Yuji Sakai},
  journal={Cancer},
  year={1990},
  volume={65 7},
  pages={1557-61}
}
Levels of serum Span-1, a new tumor marker for pancreatic cancer, were assayed in 64 patients with pancreatic cancer, 90 with nonpancreatic cancer, and 254 with nonmalignancies, involving 55 healthy controls. Furthermore, Span-1 was compared with other tumor markers (CA19-9, carcinoembryonic antigen [CEA], and DU-PAN-2). Frequency of elevated Span-1 levels was 81.3% in pancreatic cancer. False-positive elevations of serum Span-1 levels were rather common in liver cirrhosis (53.8%) and chronic… CONTINUE READING